Kiadis Pharma

AEX:KDS, NL0011323407
1,617 13:36
+0,033 ( +2,08% )
Datum Guru Advies Koersdoel Rendement
15 sep KBC Securities houden 2,80 -2,86%
14 sep KBC Securities houden 2,50 +2,80%
17 aug KBC Securities houden 2,50 -4,36%
14 jul KBC Securities houden 2,50 -5,01%
13 jul KBC Securities houden 2,50 -1,58%
09 jul KBC Securities houden 2,50 -3,49%
09 jul Jefferies & Co. houden 2,40 -13,16%
09 jul Piper Sandler kopen 4,50 -26,33%
08 jul Kempen & Co. kopen 2,70 -26,33%
12 jun KBC Securities verkopen 2,00 -30,55%
14 mei KBC Securities verkopen 2,00 -6,33%
06 mei KBC Securities kopen 2,00 +7,53%
04 mei Jefferies & Co. houden 2,00 +2,36%
04 mei KBC Securities verkopen 2,00 -4,71%
28 apr KBC Securities verkopen 2,00 -12,42%
12 dec KBC Securities verkopen 2,00 0,00%
18 nov Jefferies & Co. houden 1,50 0,00%
13 nov Oppenheimer & Co kopen 0,00 +4,55%
13 nov NIBC Markets verkopen 1,00 -4,55%
13 nov Jefferies & Co. houden 2,50 0,00%

Brussel real time stocks quotedata by Euronext. Other real time EU stocks, by Cboe Europe Ltd.; US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: VWD Group